How can OneStudyTeam balance the need for data security in its clinical trial management system with the desire for easier data sharing among research sites?

Introduction

Balancing data security and data sharing in OneStudyTeam's clinical trial management system presents a critical trade-off. This scenario involves navigating the tension between protecting sensitive patient information and facilitating efficient collaboration among research sites. I'll analyze this challenge through the lens of product strategy, user needs, and technical considerations.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking about the regulatory landscape for clinical trials. Could you provide more details on the specific data protection regulations OneStudyTeam must comply with?

Why it matters: Helps define the boundaries of our solution Expected answer: HIPAA, GDPR, and industry-specific guidelines Impact: Stricter regulations would necessitate more robust security measures

• Business Context: Based on the industry, I assume OneStudyTeam operates on a SaaS model. Is this correct, and how does data sharing impact our revenue streams?

Why it matters: Aligns solution with business model Expected answer: SaaS model with potential for premium features around data sharing Impact: Could influence whether we prioritize security or sharing features

• User Impact: I'm considering the various stakeholders in clinical trials. Who are our primary users, and how do their data needs differ?

Why it matters: Ensures solution addresses diverse user requirements Expected answer: Researchers, clinicians, administrators with varying access needs Impact: May lead to a role-based access control system

• Technical: Thinking about our current architecture, what level of granularity does our system support for data access controls?

Why it matters: Determines feasibility of fine-grained security measures Expected answer: Basic role-based access, looking to implement attribute-based access control Impact: More advanced controls could allow for nuanced data sharing policies

• Timeline: Given the sensitivity of clinical data, I imagine this is a high-priority issue. What's our timeline for implementing changes?

Why it matters: Influences the scope and approach of our solution Expected answer: Critical issue, aiming for initial improvements within 3-6 months Impact: Shorter timeline might require a phased approach, focusing on quick wins first